HuGE Literature Finder
Records
1
-
2
Effect of UGT1A1, UGT1A3, DIO1 and DIO2 polymorphisms on L-thyroxine doses required for TSH suppression in patients with differentiated thyroid cancer. British journal of clinical pharmacology 2014 Nov 78 (5): 1067-75. Santoro Ana B, Vargens Daniela D, Barros Filho Mateus de Camargo, Bulzico Daniel A, Kowalski Luiz Paulo, Meirelles Ricardo M R, Paula Daniela P, Neves Ronaldo R S, Pessoa Cencita N, Struchine Claudio J, Suarez-Kurtz Guilher |
Association of the UGT1A1-53(TA)n polymorphism with L-thyroxine doses required for thyrotropin suppression in patients with differentiated thyroid cancer. Pharmacogenetics and genomics 2011 Jun 21 (6): 341-3. Vargens Daniela D, Neves Ronaldo R S, Bulzico Daniel A, Ojopi Elida B, Meirelles Ricardo M R, Pessoa Cencita N, Prado Carolina M, Gonçalves Pedro A, Leal Vera L G, Suarez-Kurtz Guilher |
- Page last reviewed:Feb 1, 2023
- Page last updated:Feb 07, 2023
- Content source: